Background: The Maintain Your Brain (MYB) randomised controlled trial (RCT) aimed to prevent cognitive decline and dementia through a multidomain risk-reduction intervention delivered digitally. The intervention targeted four modifiable risk areas (physical inactivity, poor diet, cognitive inactivity, and depression and/or anxiety). MYB ran for three years and targeted older Australians aged 55-77 years. We previously reported significant benefits on cognition in the intervention group compared to the control group. Here we report the outcome on a validated dementia risk assessment tool.
Method: The self-reported short form of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI-SF; 1) was used to assess dementia risk in MYB. To examine risk and protective factors, non-modifiable factors (age and sex) were removed. Unrealistic values were also removed as part of the data cleaning process. A generalised linear mixed model with appropriate response distributions and link function was run to examine the group (intervention vs control) by time (baseline, 12-, 24-, and 36-months) interaction. An additional analysis adjusted for baseline age, gender, and years of education was run.
Result: Of 14,064 participants who consented, 6,104 participants were eligible and completed baseline assessments. They were randomised 1:1 to the intervention (n = 3,051) or control (n = 3,053) group. Upon removing outliers (n = 58), 6,046 participants were included in the mixed model analysis. Analysis revealed significant intervention effects on dementia risk change over three years (0.56, 95%CI -0.88- -0.30, p<0.001). Results were replicated in the adjusted model (p<0.001).
Conclusion: An online intervention program confirmed results from a 24-month follow-up of in-person multicomponent interventions (2,3) in lowering dementia risk. Overall, MYB has the potential to provide a realistic path towards scalable community-based prevention of dementia, resulting in an improvement in public health and potential economic implications. References: 1. Kim S et al, Alzheimers Dement: Translational Res & Clin Interventions 2016;2:93-98 2. Barbera et al., Alzheimers Dement J Alzheimers Assoc. 2020; 16:S10 3. Deckers K et al. Alzheimers Dement. 2021;17:1205-1212.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.090586 | DOI Listing |
Zhong Nan Da Xue Xue Bao Yi Xue Ban
July 2024
Second Ward of Endocrinology Department, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000.
Alzheimer's disease (AD) is a progressive central neurodegenerative disorder with an insidious onset. With global aging, the incidence and mortality of AD have been steadily increasing, yet effective treatments remain elusive. Obesity, characterized by excessive or abnormal fat accumulation, is a complex metabolic disorder and a confirmed risk factor for numerous diseases.
View Article and Find Full Text PDFNeuron
January 2025
Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA. Electronic address:
As global life expectancy increases, age-related brain diseases such as stroke and dementia have become leading causes of death and disability. The aging of the neurovasculature is a critical determinant of brain aging and disease risk. Neurovascular cells are particularly vulnerable to aging, which induces significant structural and functional changes in arterial, venous, and lymphatic vessels.
View Article and Find Full Text PDFEBioMedicine
January 2025
Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health (AGECAP) at the University of Gothenburg, Sweden; Department of Psychiatry, Cognition and Old Age Psychiatry, Sahlgrenska University Hospital, Region Västra Götaland, Mölndal, Sweden.
Background: A better understanding of body-brain links may provide insights on targets for preventing cognitive decline. The aim was to explore associations of body composition with neuroimaging biomarkers and cognitive function among dementia-free 70-year-olds.
Methods: Dual-energy X-ray absorptiometry body composition measures in relation to neuroimaging measures of cortical thickness, hippocampal volume, small vessel disease, predicted brain age, and cognitive performance were explored in a cross-sectional study of 674 dementia-free 70-year-olds from the Swedish Gothenburg H70 Birth Cohort study.
J Nutr Health Aging
January 2025
The Center of Gerontology and Geriatrics and National Clinical Research Center of Geriatrics, West China Hospital, Sichuan University, China. Electronic address:
Objectives: Motor cognitive risk (MCR) syndrome, defined as the cooccurrence of subjective cognitive complaints and a slow gait speed, is a form of pre-dementia condition. Balance has previously been associated with cognitive function. However, to date, no study has examined the relationship between balance and MCR in a large cohort of older adults.
View Article and Find Full Text PDFNoise Health
January 2025
Institute of Hygiene and Medical Ecology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Exposure to sound energy may be a risk factor or a therapeutic intervention for Alzheimer's disease (AD). On one hand, noise has a harmful effect on people with AD by contributing to hearing loss, sleep disturbance, oxidative stress, inflammation, and excitotoxicity. But on the other hand, clinical trials and nursing home interventions with soundscape augmentation involving natural sounds have shown promising results in alleviating psychophysiological symptoms in people with AD.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!